Cullen Capital Management, LLC - NOVARTIS AG ownership

NOVARTIS AG's ticker is and the CUSIP is H5820Q150. A total of 3 filers reported holding NOVARTIS AG in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cullen Capital Management, LLC ownership history of NOVARTIS AG
ValueSharesWeighting
Q2 2023$3,111,989
+2.8%
30,947
-6.4%
0.03%0.0%
Q1 2023$3,028,288
+28.3%
33,074
+7.3%
0.03%
+12.0%
Q3 2022$2,361,000
-2.4%
30,834
+7.9%
0.02%
+4.2%
Q2 2022$2,419,000
-19.1%
28,564
-16.0%
0.02%
-14.3%
Q1 2022$2,991,000
+8.4%
34,009
+8.5%
0.03%
+7.7%
Q4 2021$2,760,000
+15.3%
31,348
+8.0%
0.03%
+8.3%
Q3 2021$2,393,000
-9.5%
29,0190.0%0.02%
-7.7%
Q2 2021$2,644,000
+62.6%
29,019
+52.5%
0.03%
+44.4%
Q1 2021$1,626,000
+35.4%
19,025
+49.6%
0.02%
-73.1%
Q4 2020$1,201,000
+3.4%
12,720
-4.9%
0.07%0.0%
Q3 2020$1,161,000
-0.3%
13,3800.0%0.07%
+3.1%
Q2 2020$1,164,000
+26.5%
13,380
+20.7%
0.06%
+22.6%
Q1 2020$920,000
+60.8%
11,085
+84.0%
0.05%
+140.9%
Q4 2019$572,000
+9.6%
6,0250.0%0.02%
+4.8%
Q3 2019$522,000
-2.1%
6,025
+3.3%
0.02%0.0%
Q2 2019$533,000
+0.8%
5,830
+6.0%
0.02%0.0%
Q1 2019$529,000
-10.5%
5,500
-20.5%
0.02%
-16.0%
Q4 2018$591,000
-9.1%
6,915
-8.5%
0.02%
+4.2%
Q3 2018$650,000
-5.9%
7,555
-16.8%
0.02%
-7.7%
Q2 2018$691,000
+8.0%
9,085
+14.8%
0.03%
+13.0%
Q1 2018$640,000
+72.0%
7,915
+80.1%
0.02%
+76.9%
Q4 2017$372,000
-29.7%
4,395
-23.8%
0.01%
-31.6%
Q3 2015$529,000
-50.7%
5,765
-47.1%
0.02%
-44.1%
Q2 2015$1,074,000
-0.5%
10,9000.0%0.03%
+13.3%
Q1 2015$1,079,000
+6.5%
10,9000.0%0.03%
+7.1%
Q4 2014$1,013,000
-1.5%
10,9000.0%0.03%0.0%
Q3 2014$1,028,000
+4.2%
10,9000.0%0.03%
+7.7%
Q2 2014$987,000
+6.7%
10,9000.0%0.03%
+4.0%
Q1 2014$925,000
+6.0%
10,9000.0%0.02%
+8.7%
Q4 2013$873,000
+4.2%
10,9000.0%0.02%
-4.2%
Q3 2013$838,000
+8.4%
10,9000.0%0.02%
+4.3%
Q2 2013$773,00010,9000.02%
Other shareholders
NOVARTIS AG shareholders Q1 2023
NameSharesValueWeighting ↓
CHICKASAW CAPITAL MANAGEMENT LLC 29,800$2,483,0000.05%
Geneva Advisors, LLC 11,650$970,0000.02%
SILVERCREST ASSET MANAGEMENT GROUP LLC 5,200$433,0000.01%
View complete list of NOVARTIS AG shareholders